 Kansas City, Kansas--Newsfile Corp. - November 3, 2022 - Cingulate Inc. NASDAQ: CING, a biopharmaceutical company utilizing its proprietary Precision Timed ReleaseTM PTRTM drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Shane Schaffer, CEO, and Tom Dalton, Vice President of IR PR, will present a company overview at the Q4 Investor Summit live in New York City at the Sheraton Times Square. 